Immunological Biomarkers in Dermatomyositis

Jeannette M. Olazagasti, Timothy B. Niewold, Ann M. Reed

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Dermatomyositis (DM) is a chronic acquired disorder that affects primarily the muscle and skin. The pathogenesis of DM, as well as methods for monitoring disease activity and predicting response to therapy, are subjects of active research. Studies looking to unveil the pathogenesis of DM have revealed key molecules that are potential biomarkers of disease activity. This article reviews briefly the recently discovered molecules that are candidate immunological biomarkers for diagnosing and monitoring disease activity in DM.

Original languageEnglish (US)
Article number68
JournalCurrent Rheumatology Reports
Volume17
Issue number11
DOIs
StatePublished - Nov 29 2015

Keywords

  • Biomarkers
  • Chemokines
  • Cytokines
  • Dermatomyositis
  • Toll-like receptors
  • Type I interferon

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Immunological Biomarkers in Dermatomyositis'. Together they form a unique fingerprint.

  • Cite this

    Olazagasti, J. M., Niewold, T. B., & Reed, A. M. (2015). Immunological Biomarkers in Dermatomyositis. Current Rheumatology Reports, 17(11), [68]. https://doi.org/10.1007/s11926-015-0543-y